Cargando…

Frequency of MicroRNA Response Elements Identifies Pathologically Relevant Signaling Pathways in Triple-Negative Breast Cancer

Complex interactions between mRNAs and microRNAs influence cellular functions. The mRNA-microRNA interactions also determine the post-transcriptional availability of mRNAs and unbound microRNAs. MicroRNAs binds to one or more microRNA response elements (MREs) located on the 3′UTR of mRNAs. In this s...

Descripción completa

Detalles Bibliográficos
Autores principales: Nair, Asha A., Tang, Xiaojia, Thompson, Kevin J., Vedell, Peter T., Kalari, Krishna R., Subramanian, Subbaya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7322352/
https://www.ncbi.nlm.nih.gov/pubmed/32629614
http://dx.doi.org/10.1016/j.isci.2020.101249
_version_ 1783551623313752064
author Nair, Asha A.
Tang, Xiaojia
Thompson, Kevin J.
Vedell, Peter T.
Kalari, Krishna R.
Subramanian, Subbaya
author_facet Nair, Asha A.
Tang, Xiaojia
Thompson, Kevin J.
Vedell, Peter T.
Kalari, Krishna R.
Subramanian, Subbaya
author_sort Nair, Asha A.
collection PubMed
description Complex interactions between mRNAs and microRNAs influence cellular functions. The mRNA-microRNA interactions also determine the post-transcriptional availability of mRNAs and unbound microRNAs. MicroRNAs binds to one or more microRNA response elements (MREs) located on the 3′UTR of mRNAs. In this study, we leveraged MREs and their frequencies in cancer and matched normal tissues to obtain insights into disease-specific interactions between mRNAs and microRNAs. We developed a bioinformatics method “ReMIx” that utilizes RNA sequencing (RNA-Seq) data to quantify MRE frequencies across the transcriptome. We applied ReMIx to triple-negative (TN) breast cancer tumor-normal adjacent pairs and identified MREs specific to TN tumors. ReMIx identified candidate mRNAs and microRNAs in the MAPK signaling cascade. Further analysis of MAPK gene regulatory networks revealed microRNA partners that influence and modulate MAPK signaling. In conclusion, we demonstrate a novel method of using MREs in the identification of functionally relevant mRNA-microRNA interactions in TN breast cancer.
format Online
Article
Text
id pubmed-7322352
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-73223522020-06-30 Frequency of MicroRNA Response Elements Identifies Pathologically Relevant Signaling Pathways in Triple-Negative Breast Cancer Nair, Asha A. Tang, Xiaojia Thompson, Kevin J. Vedell, Peter T. Kalari, Krishna R. Subramanian, Subbaya iScience Article Complex interactions between mRNAs and microRNAs influence cellular functions. The mRNA-microRNA interactions also determine the post-transcriptional availability of mRNAs and unbound microRNAs. MicroRNAs binds to one or more microRNA response elements (MREs) located on the 3′UTR of mRNAs. In this study, we leveraged MREs and their frequencies in cancer and matched normal tissues to obtain insights into disease-specific interactions between mRNAs and microRNAs. We developed a bioinformatics method “ReMIx” that utilizes RNA sequencing (RNA-Seq) data to quantify MRE frequencies across the transcriptome. We applied ReMIx to triple-negative (TN) breast cancer tumor-normal adjacent pairs and identified MREs specific to TN tumors. ReMIx identified candidate mRNAs and microRNAs in the MAPK signaling cascade. Further analysis of MAPK gene regulatory networks revealed microRNA partners that influence and modulate MAPK signaling. In conclusion, we demonstrate a novel method of using MREs in the identification of functionally relevant mRNA-microRNA interactions in TN breast cancer. Elsevier 2020-06-06 /pmc/articles/PMC7322352/ /pubmed/32629614 http://dx.doi.org/10.1016/j.isci.2020.101249 Text en © 2020 The Author(s) http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Nair, Asha A.
Tang, Xiaojia
Thompson, Kevin J.
Vedell, Peter T.
Kalari, Krishna R.
Subramanian, Subbaya
Frequency of MicroRNA Response Elements Identifies Pathologically Relevant Signaling Pathways in Triple-Negative Breast Cancer
title Frequency of MicroRNA Response Elements Identifies Pathologically Relevant Signaling Pathways in Triple-Negative Breast Cancer
title_full Frequency of MicroRNA Response Elements Identifies Pathologically Relevant Signaling Pathways in Triple-Negative Breast Cancer
title_fullStr Frequency of MicroRNA Response Elements Identifies Pathologically Relevant Signaling Pathways in Triple-Negative Breast Cancer
title_full_unstemmed Frequency of MicroRNA Response Elements Identifies Pathologically Relevant Signaling Pathways in Triple-Negative Breast Cancer
title_short Frequency of MicroRNA Response Elements Identifies Pathologically Relevant Signaling Pathways in Triple-Negative Breast Cancer
title_sort frequency of microrna response elements identifies pathologically relevant signaling pathways in triple-negative breast cancer
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7322352/
https://www.ncbi.nlm.nih.gov/pubmed/32629614
http://dx.doi.org/10.1016/j.isci.2020.101249
work_keys_str_mv AT nairashaa frequencyofmicrornaresponseelementsidentifiespathologicallyrelevantsignalingpathwaysintriplenegativebreastcancer
AT tangxiaojia frequencyofmicrornaresponseelementsidentifiespathologicallyrelevantsignalingpathwaysintriplenegativebreastcancer
AT thompsonkevinj frequencyofmicrornaresponseelementsidentifiespathologicallyrelevantsignalingpathwaysintriplenegativebreastcancer
AT vedellpetert frequencyofmicrornaresponseelementsidentifiespathologicallyrelevantsignalingpathwaysintriplenegativebreastcancer
AT kalarikrishnar frequencyofmicrornaresponseelementsidentifiespathologicallyrelevantsignalingpathwaysintriplenegativebreastcancer
AT subramaniansubbaya frequencyofmicrornaresponseelementsidentifiespathologicallyrelevantsignalingpathwaysintriplenegativebreastcancer